Have you been contemplating whether or not to take the HPV vaccine? On National Vaccination Day 2024, Mid-day.com spoke to gynaecologists who answered common questions about the vaccine to help readers make an informed decision
The inaugural vaccine, Gardasil, was pioneered by Merck & Co. and gained FDA approval in 2006. Photo Courtesy: AFP
Given the controversy that followed after Indian model Poonam Pandey faked her death to raise awareness against cervical cancer, conversations around whether or not to take the HPV vaccine sprouted among many. However, contemplation has kept us from actually getting our shot.
On National Vaccination Day 2024 – a day observed annually on March 16 to raise awareness of the importance of vaccines for protection against deadly diseases – Mid-day.com spoke to gynaecologists who answered common questions we all have had.
Dr Madhuri Burande Laha, consultant obstetrician and gynaecologist, Motherhood Hospital, Kharadi, says, “The HPV vaccine, also known as the human papillomavirus vaccine, is a crucial tool in preventing HPV infection and its associated health risks.
Human papillomavirus (HPV) is a common sexually transmitted infection that can lead to cervical cancer.
Dr Nandita Palshetkar (@drnanditapalshetkar_bloomivf), obstetrician, gynaecologist, director of Bloom IVF India and president of IVF Society of India (ISAR) states, “The HPV vaccine works by triggering the immune system to generate antibodies targeting specific HPV strains. This proactive approach aids in averting infection and lowering the likelihood of HPV-associated conditions like cervical cancer, genital warts, and certain other cancers.”
Additionally, Dr Sampada Dessai, consultant, gynaecological cancer and robotic surgeon, P. D. Hinduja Hospital and MRC, Mahim says, “All women should be made aware of the HPV vaccine, their advantages and importance in preventing cervical cancer when taken timely.”
The HPV vaccine made its debut in the early 2000s. The inaugural vaccine, Gardasil, was pioneered by Merck & Co. and gained FDA approval in 2006. Subsequently, another vaccine named Cervarix, developed by GlaxoSmithKline, also received regulatory approval. Together, these vaccines have played a crucial role in curtailing the prevalence of HPV-related diseases on a global scale.
To continue reading this article subscribe to Mid-day GOLD
Choose Your Subscription Plan
Already a member? Login
1 YEAR DIGITAL SUBSCRIPTION
1 Year Subscription : ₹899/- ₹499/-
Best value deal!
OTHER DIGITAL SUBSCRIPTION
6 Months Subscription :₹499/-
3 Months Subscription :₹299/-
1 Month Subscription :₹99/-
Become a Mid-day GOLD member and we'll deliver the most premium news to you.
For any queries please contact us: E-mail: support@mid-day.com
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
